Abstract:Exposure to fine particulate matter (PM2.5) has been indicated to be related to an increased risk of cardiovascular diseases (CVDs) in sensitive people. However, the underlying mechanisms of PM2.5-induced CVDs are poorly understood. In the present study, PM2.5 samples were collected during winter from four cities (Taiyuan, Beijing, Hangzhou, and Guangzhou) in China. Ten-month-old C57BL/6 female mice were exposed to PM2.5 suspension at a dosage of 3 mg·kg−1 (b. w.) every other day for 4 weeks by oropharyngeal aspiration. PM2.5 from Taiyuan increased the blood pressure and the thicknesses of the left ventricular anterior and posterior walls, decreased the ratio of nucleus to cytoplasm in cardiomyocytes and reduced the systolic function of the heart in mice. Further investigation revealed that PM2.5 from Taiyuan induced lung inflammatory cytokines with up-regulated expressions of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). The mRNA expression levels of myocardial hypertrophy markers atrial natriuretic peptide and the β isoform of myosin heavy chain (ANP and β-MHC), matrix metalloproteinase 2 (MMP2), MMP9, and inflammatory cytokines TNF-α and IL-6 in the myocardium were significantly increased after exposure to PM2.5 of Taiyuan. Furthermore, PM2.5 from Taiyuan activated the IL-6/JAK2/STAT3/β-MHC signaling pathway in the myocardium. The correlation between the PM2.5 components and myocardial hypertrophy markers suggested that Zinc (Zn) and acenaphthene (AC) are related to the changes in ANP and β-MHC at the transcriptional level, respectively. The above results indicated that PM2.5 exposure induced myocardial hypertrophy in older mice, which might be related to the critical contributions of Zn and AC in PM2.5. The present study provides new insights into the mechanism of myocardial hypertrophy after PM2.5 exposure.

Preexposure to PM2.5 Exacerbates Acute Viral Myocarditis Associated with Th17 Cell.

Treg Responses Are Associated With Pm2.5-Induced Exacerbation Of Viral Myocarditis

PM2.5 Increases Mouse Blood Pressure by Activating Toll-Like Receptor 3.

PM2.5 exposure and cold stress exacerbates asthma in mice by increasing histone acetylation in IL-4 gene promoter in CD4+ T cells.

The Role of Th 17 Cells and Regulatory T Cells in Coxsackievirus B 3-Induced Myocarditis

Exposure to Particulate Matter Induces Cardiomyocytes Apoptosis after Myocardial Infarction Through NFκB Activation

VCAM-1-mediated neutrophil infiltration exacerbates ambient fine particle-induced lung injury

Card9-Mediated Ambient Pm2.5-Induced Pulmonary Injury is Associated with Th17 Cell

Fine Particulate Matter-Induced Cardiovascular Injury is Associated with NLRP3 Inflammasome Activation in Apo E-/- Mice.

PM2.5 exposure aggravates left heart failure induced pulmonary hypertension

Cardiomyopathy confers susceptibility to particulate matter-induced oxidative stress, vagal dominance, arrhythmia and pulmonary inflammation in heart failure-prone rats

Comparative studies on regional variations in PM2.5 in the induction of myocardial hypertrophy in mice

Pathogenic effects of PM2.5 on pulmonary infection and its relationship with cytokines

Imbalance of Th1 and Th2 Cells in Cardiac Injury Induced by Ambient Fine Particles

Synergistic effects of PM2.5 and viral challenge on the modulation of antiviral defence and pro-inflammatory cytokines in HBECs in vitro

[Effects of Airborne Fine Particulate Matters on Pulmonary Inflammation Injury and Th17/Treg Balance of Sub-Chronic Exposure Mice].

PM2.5 Induces Endothelial Dysfunction Via Activating NLRP3 Inflammasome

PM2.5 induce myocardial injury in hyperlipidemic mice through ROS-pyroptosis signaling pathway

PM2.5 compromises antiviral immunity in influenza infection by inhibiting activation of NLRP3 inflammasome and expression of interferon-β

The cardiotoxicity of asthmatic rats after traffic-related PM2.5 and water-soluble components exposure mediated by endoplasmic reticulum stress and autophagy

Fine particulate matter induces vascular endothelial activation via IL-6 dependent JAK1/STAT3 signaling pathway.